Titlebook: Clinical Pharmacology of Antianginal Drugs; Ulrich Abshagen (Leiter Produktentwicklung Therape Book 1985 Springer-Verlag Berlin Heidelberg

candle

Experimental Testing of Antianginal Drugs in Animalson the other hand, would fulfill some criteria for drug testing, but has the big disadvantage of being too small to allow complete hemodynamic assessment of the dysfunction or of drug effects. Another great problem is the availability of the experimental animals and the legal restrictions which furt

奇思怪想

lavish

β-Adrenoceptor Blocking Agentsbeen further divided into α., α., .. and .. receptors (L. 1976; W. and L. 1978; L. 1981; A. 1982). The first report of . adrenoceptor blocking activity came in 1958 when the properties of dichloroisoprenaline were discovered in animal experiments. This drug had powerful intrinsic sympathomimetic act

irritation

Book 1985n pathophysiology of acute coronary insufficiency. The chapter on invasive methods provided an opportunity to touch on new approaches to early intervention in acute myocardial infarction. Here, intracoronary streptokinase therapy and PTCA are considered, again with attention to the overlap between m

Arrhythmia

ETHER

强制令

Ulrich Abshagen (Leiter Produktentwicklung Therape

Vsd168

CAGE

AV-node

https://doi.org/10.1007/978-3-322-95487-9been further divided into α., α., .. and .. receptors (L. 1976; W. and L. 1978; L. 1981; A. 1982). The first report of . adrenoceptor blocking activity came in 1958 when the properties of dichloroisoprenaline were discovered in animal experiments. This drug had powerful intrinsic sympathomimetic act